Published in Exp Clin Transplant on September 01, 2008
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol (2012) 5.41
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol (2010) 2.66
Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol (2009) 2.57
Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol (2012) 2.32
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys (2006) 2.26
Management of hemangioma of the liver: surgical therapy or observation? World J Surg (2013) 2.23
Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol (2003) 1.67
The differential diagnosis and interdisciplinary treatment of anal carcinoma. Dtsch Arztebl Int (2015) 1.62
Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol (2006) 1.60
Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol (2005) 1.59
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.58
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. J Clin Oncol (2008) 1.52
Tensiometry as a decision tool for abdominal wall reconstruction with component separation. World J Surg (2009) 1.48
Right hemicolectomy with central vascular ligation in colon cancer. Surg Endosc (2012) 1.43
Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma. J Clin Invest (2016) 1.43
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol (2007) 1.43
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol (2009) 1.34
Despite aggressive histopathology survival is not impaired in young patients with colorectal cancer : CRC in patients under 50 years of age. Int J Colorectal Dis (2011) 1.20
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7. Int J Cancer (2005) 1.18
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy. Int J Cancer (2008) 1.17
Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol (2009) 1.16
Multivisceral resection for colon carcinoma. Dis Colon Rectum (2009) 1.15
Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations. Int J Colorectal Dis (2014) 1.14
Solid-pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity. Int J Clin Exp Pathol (2013) 1.11
Deep-seated huge hibernoma of soft tissue: a rare differential diagnosis of atypical lipomatous tumor/well differentiated liposarcoma. Int J Clin Exp Pathol (2013) 1.10
Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol (2008) 1.03
Treatment of ingrown toenails using a new conservative method: a prospective study comparing brace treatment with Emmert's procedure. J Am Podiatr Med Assoc (2005) 1.02
Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Int J Radiat Oncol Biol Phys (2008) 1.02
DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene. Dis Colon Rectum (2007) 1.02
Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma. Dis Colon Rectum (2005) 1.02
Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification. Cancer (2004) 1.01
Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification. J Lab Clin Med (2004) 1.00
Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer (2005) 1.00
Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation. Strahlenther Onkol (2009) 0.99
Recent results of laparoscopic surgery in inflammatory bowel disease. World J Gastroenterol (2011) 0.98
Primary signet-ring cell carcinoma of the colorectum. Langenbecks Arch Surg (2004) 0.98
Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Med Sci Monit (2010) 0.97
Personality rather than clinical variables determines quality of life after major colorectal surgery. Dis Colon Rectum (2009) 0.96
Improving the quality of colon cancer surgery through a surgical education program. Dis Colon Rectum (2010) 0.96
Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV). Med Sci Monit (2010) 0.96
Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol (2009) 0.95
Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry. Dis Colon Rectum (2009) 0.95
PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. Langenbecks Arch Surg (2008) 0.94
Evaluation of in vivo endoscopic autofluorescence spectroscopy in gastric cancer. Gastrointest Endosc (2004) 0.94
Endoscopic light-induced autofluorescence spectroscopy for the diagnosis of colorectal cancer and adenoma. J Photochem Photobiol B (2003) 0.94
Extraabdominal lymph node metastasis in gastrointestinal stromal tumors (GIST). J Gastrointest Surg (2011) 0.94
Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations. Int J Cancer (2014) 0.93
Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis (2004) 0.93
One step nucleic acid amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas. J Transl Med (2010) 0.93
Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol (2002) 0.93
Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential. Anticancer Res (2013) 0.92
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis. BMC Cancer (2005) 0.92
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial. Strahlenther Onkol (2014) 0.91
Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum (2005) 0.91
Malignant melanoma of the skin: long-term follow-up and time to first recurrence. World J Surg (2011) 0.91
Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis. Int J Radiat Oncol Biol Phys (2005) 0.91
Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases. Anticancer Res (2009) 0.91
Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care (2005) 0.91
Quality of life and patient's expectations after closure of a temporary stoma. Int J Colorectal Dis (2008) 0.90
Molecular signature for lymphatic metastasis in colorectal carcinomas. Ann Surg (2008) 0.90
Hypoxia generates a more invasive phenotype of tumour cells: an in vivo experimental setup based on the chorioallantoic membrane. Pathol Oncol Res (2009) 0.89
Bilateral sacral spinal nerve stimulation for fecal incontinence after low anterior rectum resection. Int J Colorectal Dis (2002) 0.89
Arterialisation of the portal vein as a model for the induction of hepatic fibrosis: description of microsurgical models in the rat. Transpl Int (2005) 0.88
Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2003) 0.87
The clinical value of von Willebrand factor in colorectal carcinomas. Am J Transl Res (2011) 0.87
Comparability of microarray data between amplified and non amplified RNA in colorectal carcinoma. J Biomed Biotechnol (2009) 0.87
Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res (2002) 0.87
Does anastomotic leakage affect functional outcome after rectal resection for cancer? Langenbecks Arch Surg (2003) 0.87
Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre. Liver (2002) 0.87
Cdc2 as prognostic marker in stage UICC II colon carcinomas. Eur J Cancer (2009) 0.86
Adenomatoid tumor of the adrenal gland mimicking an echinococcus cyst of the liver--a case report. Int J Surg (2006) 0.85
Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine. Cancer Lett (2004) 0.85
Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells. Int J Cancer (2004) 0.84
Endothelial cells of human colorectal cancer and healthy colon reveal phenotypic differences in culture. Lab Invest (2007) 0.84
Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. Int J Hyperthermia (2010) 0.84
Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer (2005) 0.84
Collagen foil (TissuFoil E) reduces the formation of adhesions when using polypropylene mesh for the repair of experimental abdominal wall defects. Int J Colorectal Dis (2006) 0.83
Changes in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study. Int J Colorectal Dis (2006) 0.83
Indications and long-term outcome after elective surgery for hepatocellular adenoma. Am Surg (2012) 0.83
Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol (2014) 0.83
Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. Exp Mol Pathol (2009) 0.82
Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI). Cancer Lett (2004) 0.82
The importance of radiological controls of anastomoses after upper gastrointestinal tract surgery - a retrospective cohort study. Patient Saf Surg (2010) 0.82
An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy. Virchows Arch (2010) 0.82
Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project. Support Care Cancer (2013) 0.82
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). Case Rep Oncol (2011) 0.82
Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg (2012) 0.81
Hepatic gene expression during endotoxemia. J Surg Res (2008) 0.81
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trial. Radiother Oncol (2013) 0.81
Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract. Int J Clin Exp Pathol (2012) 0.81
P27 does not predict histopathological response to radiochemotherapy in rectal cancer. J Surg Res (2003) 0.81
Outcome of patients with pre-existing portal vein thrombosis undergoing arterialization of the portal vein during liver transplantation. Transpl Int (2002) 0.81
Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial. Anticancer Drugs (2009) 0.81
MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant? Ann Surg Oncol (2013) 0.81